84-5410-53 [取扱停止]ASCL1 30ul 533289
特徴
- ASCL1 encodes a member of the basic helix-loop-helix (BHLH) family of transcription factors.
- The protein activates transcription by binding to the E box (5'-CANNTG-3').
- Dimerization with other BHLH proteins is required for efficient DNA binding.
- This protein plays a role in the neuronal commitment and differentiation and in the generation of olfactory and autonomic neurons.
- Mutations in ASCL1 may contribute to the congenital central hypoventilation syndrome (CCHS) phenotype in rare cases.
- ASCL1 (Achaete-Scute Family BHLH Transcription Factor 1) is a Protein Coding gene.
- Diseases associated with ASCL1 include central hypoventilation syndrome, congenital and differentiating neuroblastoma.
- Among its related pathways are dopaminergic neurogenesis and notch-mediated HES/HEY network.
- Applications:Suitable for use in Immunohistochemistry and ELISA.
- Other applications not tested.
- Recommended Dilution:Immunohistochemistry (paraffin): 1:50-1:200ELISA: 1:10,000-1:20,000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:30ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid in PBS, pH 7.4, 0.02% sodium azide, 50% glycerol.
- Specificity:Recognizes endogenous levels of human ASCL1. Species Crossreactivity: mouse and rat
- Isotype:IgG
- Calc Applications Abbrev:E IHC
- Calc Crossreactivity:Hu Mo Rt
- Immunogen:Synthetic peptide corresponding to aa190-236 from human ASCL1.
- Swiss Prot Number:P50553
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]